The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
Abstract
Islets of patients with type 2 diabetes mellitus (T2DM) display features of an inflammatory process including elevated levels of the cytokine IL-1β, various chemokines, and macrophages. IL-1β is a master regulator of inflammation, and IL-1 receptor type I (IL-1RI) blockage improves glycemia and insulin secretion in humans with T2DM and in high-fat-fed mice pointing to a pivotal role of IL-1RI activity in intra-islet inflammation. Given the association of dyslipidemia and T2DM, we tested whether free fatty acids (FFA) promote the expression of proinflammatory factors in human and mouse islets and investigated a role for the IL-1RI in this response. A comparison of 22 mouse tissues revealed the highest IL-1RI expression levels in islets and MIN6 β-cells. FFA induced IL-1β, IL-6, and IL-8 in human islets and IL-1β and KC in mouse islets. Elevated glucose concentrations enhanced FFA-induced proinflammatory factors in human islets. Blocking the IL-1RI with the IL-1R antagonist (IL-1Ra) strongly inhibited FFA-mediated expression of proinflammatory factors in human and mouse islets. Antibody inhibition of IL-1β revealed that FFA stimulated IL-1RI activity via the induction of the receptor ligand. FFA-induced IL-1β and KC expression in mouse islets was completely dependent on the IL-1R/Toll-like receptor (TLR) docking protein Myd88 and partly dependent on TLR2 and -4. Activation of TLR2 in purified human β-cells and islets stimulated the expression of proinflammatory factors, and IL-1RI activity increased the TLR2 response in human islets. We conclude that FFA and TLR stimulation induce proinflammatory factors in islets and that IL-1RI engagement results in signal amplification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
Self-citationRetractedAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · cited 3×
“TLR2 and TLR4 are activated by FFA (26, 27, 37, 38), and TLR4 deficiency protects from the induction of inflammatory markers and insulin resistance induced by high-fat feeding (26, 27).”
BackgroundImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“matory processes in various tissues (11).”
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Molecular aspects of ligand binding to serum albumin.
Kragh-Hansen, U. (1981) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06849-8 · Cited by 1,544
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Self-citationLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Self-citationPancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citationThe interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress
O'Neill, L. A. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00701.x · Cited by 616
Kharroubi, I., Ladrière, L., Cardozo, A. K., Dogusan, Z., Cnop, M., & Eizirik, D. L. (2004) · Endocrinology · doi:10.1210/en.2004-0478 · Cited by 582
Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
Self-citationMaedler, K., Oberholzer, J., Bucher, P., Spinas, G. A., & Donath, M. Y. (2003) · Diabetes · doi:10.2337/diabetes.52.3.726 · Cited by 549
Self-citationThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., & Hwang, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312990200 · Cited by 493
Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes
Song, M. J., Kim, K. H., Yoon, J. M., & Kim, J. B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.170 · Cited by 453
Meydani, S. N., Lichtenstein, A. H., Cornwall, S., Meydani, M., Goldin, B. R., Rasmussen, H., Dinarello, C. A., & Schaefer, E. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116537 · Cited by 357
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Ehses, J. A., Lacraz, G., Giroix, M.-H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J.-C., Kergoat, M., Portha, B., Homo-Delarche, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810087106 · Cited by 347
Self-citationBöni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J. A., Kerr-Conte, J., Pattou, F., Halban, P. A., Weir, G. C., & Donath, M. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0396 · Cited by 320
Self-citationCutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284 · cited 1×
“Possible examples are endotoxins, which are elevated in obesity (64) or the inflammatory marker serum amyloid A, which binds to TLR2 (65).”
BackgroundIvarsson, R., Quintens, R., Dejonghe, S., Tsukamoto, K., in ’t Veld, P., Renström, E., & Schuit, F. C. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2132 · Cited by 265
Self-citationLeptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets
Maedler, K., Sergeev, P., Ehses, J. A., Mathe, Z., Bosco, D., Berney, T., Dayer, J.-M., Reinecke, M., Halban, P. A., & Donath, M. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305683101 · Cited by 249
Self-citationInduction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages
Håversen, L., Danielsson, K. N., Fogelstrand, L., & Wiklund, O. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.033 · Cited by 237
Proliferation of sorted human and rat beta cells
Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0855-1 · Cited by 232
Self-citationPancreatic Ectopic Fat Is Characterized by Adipocyte Infiltration and Altered Lipid Composition
Pinnick, K. E., Collins, S. C., Londos, C., Gauguier, D., Clark, A., & Fielding, B. A. (2008) · Obesity · doi:10.1038/oby.2007.110 · Cited by 226
Islet Inflammation and Fibrosis in a Spontaneous Model of Type 2 Diabetes, the GK Rat
Homo-Delarche, F., Calderari, S., Irminger, J.-C., Gangnerau, M.-N., Coulaud, J., Rickenbach, K., Dolz, M., Halban, P., Portha, B., & Serradas, P. (2006) · Diabetes · doi:10.2337/db05-1526 · Cited by 213
Using Ribosomal Protein Genes as Reference: A Tale of Caution
Thorrez, L., Van Deun, K., Tranchevent, L.-C., Van Lommel, L., Engelen, K., Marchal, K., Moreau, Y., Van Mechelen, I., & Schuit, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001854 · Cited by 208
Self-citationSauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198
Busch, A. K., Cordery, D., Denyer, G. S., & Biden, T. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.977 · Cited by 184
Uptake of individual free fatty acids by skeletal muscle and liver in man
Hagenfeldt, L., Wahren, J., Pernow, B., & Räf, L. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107043 · Cited by 170
Palmitate-Induced Interleukin-6 Expression in Human Coronary Artery Endothelial Cells
Staiger, H., Staiger, K., Stefan, N., Wahl, H. G., Machicao, F., Kellerer, M., & Häring, H.-U. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3209 · Cited by 169
Vives‐Pi, M., Somoza, N., Fernández-Álvarez, J., Vargas, F., CARO, P., ALBA, A., Gomis, R., Labéta, M. O., & Pujol‐Borrell, R. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02211.x · Cited by 164
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
Osborn, O., Brownell, S. E., Sanchez-Alavez, M., Salomon, D., Gram, H., & Bartfai, T. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.004 · Cited by 160 · cited 1×
“In humans with T2DM (15, 16), in high-fat-fed mice (17, 18) and in the GK rat (19), blockage of IL-1 activity with the IL-1 receptor (IL-1R) antagonist (IL-1Ra) or with an IL-1 -inhibiting antibody results in improved insulin secretion and glycemia.”
BackgroundOrtis, F., Pirot, P., Naamane, N., Kreins, A. Y., Rasschaert, J., Moore, F., Théâtre, E., Verhaeghe, C., Magnusson, N. E., Chariot, A., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0999-7 · Cited by 158
Identification and Purification of Functional Human β-cells by a New Specific Zinc-fluorescent Probe
Lukowiak, B., Vandewalle, B., Riachy, R., Kerr-Conte, J. A., Gmyr, V., Belaich, S., Lefèbvre, J., & Pattou, F. N. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900412 · Cited by 152
Self-citationExperimental reduction of B‐cell mass: Implications for the pathogenesis of diabetes
Weir, G. C., Leahy, J. L., & Bonner‐Weir, S. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020108 · Cited by 137
The Interleukin‐1 Receptor Family
Boraschi, D., & Tagliabue, A. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74009-2 · Cited by 133
Macrophages, cytokines and β-cell death in Type 2 diabetes
Ehses, J. A., Böni‐Schnetzler, M., Faulenbach, M. V., & Donath, M. Y. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360340 · Cited by 118
Self-citationRescue Purification Maximizes the Use of Human Islet Preparations for Transplantation
Ichii, H., Pileggi, A., Molano, R., Baidal, D., Khan, A., Kuroda, Y., Inverardi, L., Goss, J. A., Alejandro, R., & Ricordi, C. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00698.x · Cited by 116
New Insights into Fatty Acid Modulation of Pancreatic β‐Cell Function
Haber, E. P., Procópio, J., Carvalho, C. R. D. O., Carpinelli, Â. R., Newsholme, P., & Curi, R. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)48001-3 · Cited by 110
Blanco, A. M. A., Pérez-Aragó, A., Fernández‐Lizarbe, S., & Guerri, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05425.x · Cited by 94
Koshkin, V., Dai, F. F., Doucette, C. A., Chan, C. B., & Wheeler, M. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705652200 · Cited by 91
Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes
Deyerle, K. L., Sims, J. E., Dower, S., & Bothwell, M. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1657 · Cited by 87
Brikos, C., Wait, R., Begum, S., O'Neill, L. A. J., & Saklatvala, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600455-mcp200 · Cited by 79
The Fas pathway is involved in pancreatic β cell secretory function
Schumann, D., Maedler, K., Franklin, I., Konrad, D., Størling, J., Böni‐Schnetzler, M., Gjinovci, A., Kurrer, M. O., Gauthier, B. R., Bosco, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611487104 · Cited by 78
Self-citationBöni‐Schnetzler, M., Ehses, J. A., Faulenbach, M. V., & Donath, M. Y. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00950.x · Cited by 63
Self-citationLommel, L. V., Janssens, K., Quintens, R., Tsukamoto, K., Mierde, D. V., Lemaire, K., Denef, C., Jonas, J., Martens, G. A., PIPELEERS, D. G., et al. (2006) · Diabetes · doi:10.2337/db06-0774 · Cited by 56
Self-citationRibaux, P., Ehses, J. A., Lin-Marq, N., Carrozzino, F., Böni‐Schnetzler, M., Hammar, E. B., Irminger, J.-C., Donath, M. Y., & Halban, P. A. (2007) · Endocrinology · doi:10.1210/en.2007-0325 · Cited by 54
Self-citationBikopoulos, G. J., Pimenta, A. D. S., Lee, S. J. C., Lakey, J. R. T., Der, S. D., Chan, C. B., Ceddia, R. B., Wheeler, M. B., & Rozakis-Adcock, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0174 · Cited by 50
Bassilian, S., Ahmed, S. M., Lim, S. K., Boros, L. G., Mao, C. S., & Lee, W.-N. P. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2001 · Cited by 43
Gmyr, V., Belaich, S., Muharram, G., Lukowiak, B., Vandewalle, B., Pattou, F. N., & Kerr-Conte, J. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.125 · Cited by 40
Self-citationFei, H., Zhao, B., Zhao, S., & Wang, Q. L. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9791-8 · Cited by 33
Senn, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.a109.513304 · Cited by 8 · cited 1×
“Studies investigating stimulatory effects of FFA on inflammatory cytokine expression have been conducted in muscle (25), in macrophage and adipocyte (26–28) cell lines, and in coronary artery endothelial cells (29).”
Background
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Self-citationInflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Self-citationInflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.006 · Cited by 1,981
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Metadata
- Authors
- Böni-Schnetzler, M., Boller, S., Debray, S., Bouzakri, K., Meier, D. T., Prazak, R., Kerr-Conte, J., Pattou, F., Ehses, J. A., Schuit, F. C., & Donath, M. Y.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-10-09
- Volume
- 150
- Issue
- 12
- Pages
- 5218-5229
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1990902267
- Cited by
- 339
- References
- 63
- FWCI
- 18.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.